Montysolv LC Junior Syrup

Montysolv LC Junior Syrup

Montelukast Sodium IP equivalent to Montelukast 4 mg + Levocetirizine Dihydrochloride IP 2.5 mg per 5 ml

4 mg + 2.5 mg per 5 ml

Indications

  • Seasonal and perennial allergic rhinitis in children
  • Allergic rhinitis with coexisting mild persistent asthma, where both antihistamine and leukotriene cover are wanted
  • Prophylaxis of asthma symptoms with an allergic trigger, as part of a physician-directed plan
  • Chronic idiopathic urticaria and allergic skin itch attributable to the levocetirizine component

Contraindications

  • Known hypersensitivity to montelukast, levocetirizine, cetirizine, hydroxyzine or any piperazine derivative
  • Severe renal impairment or end-stage renal disease, in which levocetirizine is unsuitable
  • Children below the age for which the prescriber judges this strength appropriate, and any child with a history of neuropsychiatric reaction to montelukast
  • Acute asthma attack – this syrup is not a reliever and must not replace a rescue inhaler

Side effects

  • Drowsiness, tiredness or reduced attention in some children
  • Headache, dry mouth or abdominal pain
  • Reduced appetite, nausea or loose stools
  • Neuropsychiatric effects reported with montelukast, including sleep disturbance, nightmares, irritability and mood change – stop and contact the physician if these appear

Important: This information is provided for educational purposes only and is not a substitute for professional medical advice. Please consult a Registered Medical Practitioner before starting, stopping, or changing any medication. Manufactured and marketed under Indian DCGI regulations.

Product information sheet

Montysolv LC Junior Syrup product information sheet — Montelukast Sodium IP equivalent to Montelukast 4 mg + Levocetirizine Dihydrochloride IP 2.5 mg per 5 ml
From the Allomedix product portfolio. Open the PDF

Frequently asked questions

What is Montysolv LC Junior syrup used for in children?

It contains Montelukast 4 mg with Levocetirizine Dihydrochloride 2.5 mg per 5 ml and is prescribed for allergic rhinitis in children, including cases with coexisting mild persistent asthma, and for allergic itch or urticaria. Give it only as directed by your physician.

Is Montysolv LC Junior the same as Montymist-LC?

No. They are different brands. Montymist-LC is an adult film-coated tablet containing Montelukast 10 mg with Levocetirizine 5 mg. Montysolv LC Junior is a paediatric syrup at half those strengths – 4 mg and 2.5 mg per 5 ml. The brand stems Montysolv and Montymist are not interchangeable.

What bottle sizes does Montysolv LC Junior syrup come in?

The syrup is available as a 30 ml bottle and a 60 ml bottle. Both contain the same formulation – Montelukast 4 mg with Levocetirizine Dihydrochloride 2.5 mg per 5 ml – so the choice is simply about the length of the course prescribed.

Related Products

More from the same therapeutic area.